93 3196 93 3196
Pill imprint 93 3196 93 3196 has been identified as Cefadroxil monohydate 500 mg.
Cefadroxil is used in the treatment of impetigo; upper respiratory tract infection; kidney infections; tonsillitis/pharyngitis; skin and structure infection (and more), and belongs to the drug class first generation cephalosporins. There is no proven risk in humans during pregnancy.
Cefadroxil 500 mg is not subject to the Controlled Substances Act.
See also related documents.
Cefadroxil monohydate Images
- Imprint:
-
93 3196
93 3196 - Strength:
- 500 mg
- Color:
- Orange & White
- Size:
- 22.00 mm
- Shape:
- Egg-shape
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide
croscarmellose sodium
D&C Yellow No. 10
aluminum oxide
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
gelatin
ferrosoferric oxide
magnesium stearate
propylene glycol
shellac
sodium lauryl sulfate
titanium dioxide
- Drug Class:
- First generation cephalosporins
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 00093-3196
| NDC Code | Manufacturer / Repackager |
|---|---|
| 21695-0427 | Rebel Distributors Corp (repackager) |
Note: Inactive ingredients may vary.
More Cefadroxil Monohydate resources
- Cefadroxil (Wolters Kluwer)
- Cefadroxil Suspension (Wolters Kluwer)
- cefadroxil (Cerner Multum)
- cefadroxil (Micromedex) - Includes Dosage Information
- Cefadroxil (AHFS DI)
- Cefadroxil (FDA)
- Cefadroxil Capsules (FDA)
- Cefadroxil Oral Suspension (FDA)
- Cefadroxil (Wolters Kluwer)


